// App-Quantinova.ai

11035 : Intra-patient genomic heterogeneity of single circulating tumor cells (CTCs) associated to phenotypic CTC heterogeneity in metastatic castrate resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Mark Landers

Principal Investigators

  • Stephanie Greene

  • Nicole A. Schreiber

  • Ryan Vance Dittamore

  • Daniel Costin Danila

  • Dana E. Rathkopf

  • Martin Fleisher

  • Jessica Louw

  • Adam Jendrisak

  • Dena Marrinucci

Medical Centers

  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

  • Memorial Sloan Kettering Cancer Center, New York, NYEpic Sciences, Inc., San Diego, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved